[go: up one dir, main page]

NO970087D0 - Urea- og tiourea-azolonderivater med anti-Helicobacteraktivitet - Google Patents

Urea- og tiourea-azolonderivater med anti-Helicobacteraktivitet

Info

Publication number
NO970087D0
NO970087D0 NO970087A NO970087A NO970087D0 NO 970087 D0 NO970087 D0 NO 970087D0 NO 970087 A NO970087 A NO 970087A NO 970087 A NO970087 A NO 970087A NO 970087 D0 NO970087 D0 NO 970087D0
Authority
NO
Norway
Prior art keywords
thiourea
urea
helicobacter activity
azolone
derivatives
Prior art date
Application number
NO970087A
Other languages
English (en)
Other versions
NO970087L (no
Inventor
Jan Heeres
Raymond Antoine Stokbroekx
Marc Willems
Marcel Jozef Maria Van Der Aa
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO970087D0 publication Critical patent/NO970087D0/no
Publication of NO970087L publication Critical patent/NO970087L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO970087A 1994-07-12 1997-01-09 Urea- og tiourea-azolonderivater med anti-Helicobacteraktivitet NO970087L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202017 1994-07-12
PCT/EP1995/002617 WO1996001820A1 (en) 1994-07-12 1995-07-05 Anti-helicobacter urea and thiourea derivatives of azolones

Publications (2)

Publication Number Publication Date
NO970087D0 true NO970087D0 (no) 1997-01-09
NO970087L NO970087L (no) 1997-03-10

Family

ID=8217030

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970087A NO970087L (no) 1994-07-12 1997-01-09 Urea- og tiourea-azolonderivater med anti-Helicobacteraktivitet

Country Status (18)

Country Link
US (2) US5639754A (no)
JP (1) JPH10502384A (no)
KR (1) KR970704738A (no)
CN (1) CN1071330C (no)
AU (1) AU684987B2 (no)
BR (1) BR9508378A (no)
CA (1) CA2194565A1 (no)
CZ (1) CZ2597A3 (no)
FI (1) FI970111A0 (no)
HU (1) HUT76647A (no)
IL (1) IL114535A (no)
MX (1) MX9700339A (no)
NO (1) NO970087L (no)
NZ (1) NZ290117A (no)
PL (1) PL318141A1 (no)
SK (1) SK4597A3 (no)
WO (1) WO1996001820A1 (no)
ZA (1) ZA955754B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
NZ521241A (en) * 2000-03-07 2004-02-27 Ranbaxy Lab Ltd Azole compounds as therapeutic agents for fungal infections
MXPA03000458A (es) 2000-07-20 2004-06-02 Neurogen Corp Ligandos receptores de capsaicina.
DE60234812D1 (de) 2001-01-29 2010-02-04 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält
CA2517291C (en) * 2003-03-19 2012-05-08 Exelixis, Inc. Ortho-substituted aryl and heteroaryl tie-2 modulators and methods of use
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
CA2618653A1 (en) * 2005-08-12 2007-02-22 Takeda Pharmaceutical Company Limited Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder
JP5464709B2 (ja) 2007-06-08 2014-04-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピペリジン/ピペラジン誘導体
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine / piperazine derivatives
US8835437B2 (en) 2007-06-08 2014-09-16 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
PA8783601A1 (es) 2007-06-08 2009-01-23 Janssen Pharmaceutica Nv Derivados de piperidina/piperazina
EP2222636B1 (en) 2007-12-21 2013-04-10 Ligand Pharmaceuticals Inc. Selective androgen receptor modulators (sarms) and uses thereof
PE20140572A1 (es) 2008-06-05 2014-05-16 Janssen Pharmaceutica Nv Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar
WO2012158844A1 (en) 2011-05-17 2012-11-22 Shionogi & Co., Ltd. Heterocyclic compounds
WO2015181676A1 (en) 2014-05-30 2015-12-03 Pfizer Inc. Carbonitrile derivatives as selective androgen receptor modulators
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791111A (en) * 1985-12-23 1988-12-13 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles having anti-microbial properties
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
TW218017B (no) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
TW279864B (no) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv
US5571811A (en) * 1994-07-12 1996-11-05 Janssen Pharmaceutica N.V. Sulfonamide derivatives of azolones
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones

Also Published As

Publication number Publication date
IL114535A0 (en) 1995-11-27
NO970087L (no) 1997-03-10
CZ2597A3 (en) 1997-10-15
CN1152309A (zh) 1997-06-18
FI970111A (fi) 1997-01-10
KR970704738A (ko) 1997-09-06
MX9700339A (es) 1997-05-31
US5639754A (en) 1997-06-17
IL114535A (en) 1999-04-11
CN1071330C (zh) 2001-09-19
US5811426A (en) 1998-09-22
NZ290117A (en) 1997-11-24
BR9508378A (pt) 1997-10-28
WO1996001820A1 (en) 1996-01-25
FI970111A0 (fi) 1997-01-10
CA2194565A1 (en) 1996-01-25
HU9700078D0 (en) 1997-02-28
PL318141A1 (en) 1997-05-12
JPH10502384A (ja) 1998-03-03
HUT76647A (en) 1997-10-28
SK4597A3 (en) 1997-11-05
AU3075695A (en) 1996-02-09
AU684987B2 (en) 1998-01-08
ZA955754B (en) 1997-01-13

Similar Documents

Publication Publication Date Title
NO970087D0 (no) Urea- og tiourea-azolonderivater med anti-Helicobacteraktivitet
NO970088L (no) Acylazolonderivater med anti-Helicobacteraktivitet
TR199501209A2 (tr) Urea türevleri
IL130855A0 (en) Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
NO982884L (no) Fenyl- og aminofenyl-alkylsulfonamid og ureaderivater
DE69720051D1 (de) Harnstoffderivate
DE19580279T1 (de) Schlüsselanhänger- und Befestigung
FI971749A (fi) Lipolyyttistä aktiivisuutta omaava entsyymi
DK0973534T3 (da) Planteekstrakter med appetitundertrykkende aktivitet
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
NO952039D0 (no) Proteiner med glykosyltransferase-aktivitet
DK658687D0 (da) Benzamid- og thiobenzamidderivater
BR9508264A (pt) Estrutura e artigo absorventes
NO985227D0 (no) Alkylaminobenzothiazol og -benzoksazol - derivater
NO970086D0 (no) Heterocykliske azolonderivater med anti-Helicobacteraktivitet
DE69333528D1 (de) D-n-carbamoylaminosaureamidohydrolase und hydantoinase
NO992103L (no) Dihydropyroner med forbedret antiviral aktivitet
DE69505475D1 (de) Harnstoff- oder Thioharnstoff-Derivat und wärmeempfindliche Aufzeichnungsschicht
DK51589A (da) 5-substituerede ornithinderivater samt anvendelse heraf
SI0964849T1 (en) Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
DK0731078T3 (da) Terpenquinon med antitumoraktivitet
FI925468A (fi) Kinolylmetoxifenylaettiksyraacylamider och -ureor
DE69942722D1 (de) Mikrobenkultur mit erhöhter glutaminase-aktivität und ihre verwendung
FI97921B (fi) Integroitu akku-kondensaattori sekä sen käyttö
KR940014599U (ko) 수면시 코골기 및 이갈이 방지구

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application